Ashish Kacholia gains Rs 10,57,38,272 from this multibagger speciality chemicals stock in just 1 day after reporting stellar Q1FY26 results!

On Thursday, the stock market was trading in red with the Sensex and the Nifty-50 indices down over 0.30 per cent each. Though the market was in red, shares of this speciality chemicals company jumped 9.04 per cent to Rs 1,329.10 per share from its previous closing of Rs 1,218.95 per share. The stock also hit a fresh 52-week high of Rs 1345 per share while its 52-week low is Rs 600 per share. The shares of the company saw a spurt in volume by more than 6 times on the BSE.

The stock name is ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited)

Acutaas Chemicals Limited, a prominent global speciality chemicals manufacturer serving a wide range of industries, has announced robust financial results for the first quarter of fiscal year 2026, ending June 30, 2025. The company reported a significant 17.3 per cent year-over-year increase in Revenue from Operations, reaching Rs 207.2 crore. This growth was accompanied by substantial improvements in profitability, with the EBITDA margin expanding by 785 basis points year-over-year to 24.6 per cent and the gross margin improving to 53.2 per cent, up 1,117 basis points.

The company's performance also saw a remarkable surge in its Profit After Tax (PAT), which grew by 199.6 per cent year-over-year to Rs 44 crore, resulting in a PAT margin of 21.2 per cent, an increase of 1,292 basis points. Exports contributed significantly to the revenue, accounting for 60 per cent of the business, while the domestic market made up the remaining 40 per cent. These strong results underscore Acutaas Chemicals' effective operational strategies and its leading position in the speciality chemicals sector.

Commenting on results, Mr. Naresh Patel, Executive Chairman & Managing Director, Ami Organics Limited, said: “I am happy to share that we’ve had a strong start to FY26, with Q1 revenue growing 17.3 per cent year-on-year, driven by robust performance in our Pharmaceutical Intermediates business. Both our pharma facilities are now PMDA GMP certified, underscoring our commitment to global compliance and quality. I am happy to announce that we have entered into a joint venture in South Korea, which brings us closer to key semiconductor markets and strengthens our portfolio with differentiated, high-value products tailored for this space. With rising customer engagement across COMO, battery chemicals and semiconductors, we step into FY26 with strong momentum and confidence to deliver 25 per cent growth with improved margins.”

ABOUT ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited)

Acutaas Chemicals Limited stands as a versatile speciality chemicals manufacturer, providing critical materials across diverse sectors such as pharmaceuticals, semiconductors, battery chemicals, personal care, agrochemicals and fine chemicals. The company's primary expertise lies in the research-driven development and production of advanced pharmaceutical intermediates, essential for both regulated and generic Active Pharmaceutical Ingredients (APIs), as well as New Chemical Entities (NCEs). Furthermore, Acutaas Chemicals is strategically broadening its portfolio to encompass high-value specialty chemicals tailored for cutting-edge technologies, including battery materials, semiconductors and next-generation electronic applications, alongside established products like parabens, methyl salicylate and various niche key starting materials (KSMs) for the cosmetics and industrial segments.

The company has a market cap of over Rs 10,000 crore and its almost debt-free. The stock gave multibagger returns of over 120 per cent from its 52-week low of Rs 600 per share. An ace investor, Ashish Kacholia, owns 9,59,948 shares or a 1.17 per cent stake in the company. In just 1 day, Ashish Kacholia gains Rs 10,57,38,272 from this multibagger speciality chemicals stock.

Disclaimer: The article is for informational purposes only and not investment advice.